• Monday, Sep 27, 2021
  • Last Update : 12:58 am

Study: Sinopharm's Covid shot offers weaker protection among elderly

  • Published at 09:01 am July 24th, 2021
Sinopharm vaccine
File photo of the Covid-19 vaccine made by the Beijing Institute of Biological Products, a unit of Sinopharm subsidiary China National Biotec Group (CNBG), taken on April 15, 2021 Reuters

The study has yet to be peer-reviewed

Sinopharm’s Covid-19 vaccine was less effective in offering protection against the disease among the elderly, according to the results of a Hungarian study.

The study of 450 participants who had received two doses of the vaccine showed measurable antibody levels were present in about 90% of people under the age of 50, but the protection reduced as age increased.

The estimated probability of no antibody response was about 25% in people aged 60 and about 50% at the age of 80 years, according to the study, which was published on medRxiv earlier this week and has not been peer-reviewed.

Several elderly subjects were unable to produce any protective antibodies, suggesting that measures should be put in place to prevent an outbreak of Covid-19 among them, the study’s authors said.

But the authors warned that the reliable estimation of a direct relationship between the risk of the Covid-19 disease, hospitalization, or death and the antibody levels after vaccination is extremely difficult.


Also Read - Covid: Bangladesh receives another 2 million Sinopharm vaccine doses from China


Sinopharm, formally known as China National Pharmaceutical Group, was not immediately available for comment.

The two-dose vaccine is one of the most widely used Covid-19 shots in China, and Sinopharm has agreed to provide up to 170 million doses of the shot to the global vaccine sharing scheme Covax through to the middle of 2022.

A recent study showed the vaccine elicited weaker antibody responses against the Delta variant, which was first found in India and is now the dominant variant worldwide.

113
Facebook 97
blogger sharing button blogger
buffer sharing button buffer
diaspora sharing button diaspora
digg sharing button digg
douban sharing button douban
email sharing button email
evernote sharing button evernote
flipboard sharing button flipboard
pocket sharing button getpocket
github sharing button github
gmail sharing button gmail
googlebookmarks sharing button googlebookmarks
hackernews sharing button hackernews
instapaper sharing button instapaper
line sharing button line
linkedin sharing button linkedin
livejournal sharing button livejournal
mailru sharing button mailru
medium sharing button medium
meneame sharing button meneame
messenger sharing button messenger
odnoklassniki sharing button odnoklassniki
pinterest sharing button pinterest
print sharing button print
qzone sharing button qzone
reddit sharing button reddit
refind sharing button refind
renren sharing button renren
skype sharing button skype
snapchat sharing button snapchat
surfingbird sharing button surfingbird
telegram sharing button telegram
tumblr sharing button tumblr
twitter sharing button twitter
vk sharing button vk
wechat sharing button wechat
weibo sharing button weibo
whatsapp sharing button whatsapp
wordpress sharing button wordpress
xing sharing button xing
yahoomail sharing button yahoomail